Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal CancerSean Dineen, Patrick M Lynch, Miguel A Rodriguez-Bigas, et al.Journal of Tissue Viability|November 9, 2019
Public & patient involvement to guide research in wound care in an Irish context. A round table reportMarion O'Regan, Georgina Gethin, Aonghus O'Loughlin, et al.Molecular and Cellular Biology|June 24, 2009
Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissueNils Halberg, Tayeba Khan, Maria E Trujillo, et al.Anticancer Research|July 5, 2018
Neoadjuvant <i>Nab</i>-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOXShawn L Peterson, Muhammad Husnain, Terri Pollack, et al.The Journal of Surgical Research|May 7, 2022
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?Eliza W Beal, J C Chen, Alex Kim, et al.Frontiers in Oncology|January 24, 2025
Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySamantha M Ruff, Gyulnara Kasumova, Manoj Palavalli, et al.World Journal of Surgery|April 28, 2025
Predicting Severe Postoperative Complications after CRS-HIPEC: An Externally Validated Machine-Learning ToolAmir Ashraf Ganjouei, Jane Wang, Christopher Yi, et al.The Journal of Surgical Research|September 4, 2023
Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal CancerGopika SenthilKumar, Jennifer Merrill, Ugwuji N Maduekwe, et al.The Journal of Surgical Research|October 8, 2023
Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal ChemotherapyIsabella Florissi, Shannon N Radomski, Benjamin Shou, et al.Journal of Surgical Oncology|December 5, 2022
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPECBoateng Kubi, Richard Nudotor, Nadege Fackche, et al.Pageof 5